These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37837430)

  • 1. Molecular interaction analysis of anti-IL-8 scFv-10F8-6His against IL-8 monomer through molecular docking and molecular dynamic simulations.
    Abdul Kadir FFN; Che Nordin MA; S M N Mydin RB; Choong YS; Che Omar MT
    J Biomol Struct Dyn; 2023 Oct; ():1-11. PubMed ID: 37837430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis.
    Skov L; Beurskens FJ; Zachariae CO; Reitamo S; Teeling J; Satijn D; Knudsen KM; Boot EP; Hudson D; Baadsgaard O; Parren PW; van de Winkel JG
    J Immunol; 2008 Jul; 181(1):669-79. PubMed ID: 18566434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual discovery of a hetero-cyclic compound from the Universal Natural Product Database (UNPD36) as a potential inhibitor of interleukin-33: molecular docking and dynamic simulations.
    Adamu RM; Singh RM; Ibrahim MA; Uba AI
    J Biomol Struct Dyn; 2022; 40(19):8696-8705. PubMed ID: 33896389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potential sclerostin inhibitors from plants with loop2 region of sclerostin inhibition by interacting with residues outside Pro-Asn-Ala-Ile-Gly motif.
    Yooin W; Saenjum C; Ruangsuriya J; Jiranusornkul S
    J Biomol Struct Dyn; 2020 Mar; 38(5):1272-1282. PubMed ID: 30907243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative molecular docking analysis for analyzing the inhibitory effect of Anakinra and Ustekinumab against IL17F.
    Nisar H; Attique SA; Javaid A; Ain QU; Butt F; Zaid M; Shahid S; Hassan Nasir M; Sadaf S
    J Biomol Struct Dyn; 2023; 41(22):13302-13313. PubMed ID: 36715128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Binding Modes of Antigen-Antibody Complexes by Molecular Mechanics Calculation.
    Qu L; Qiao X; Qi F; Nishida N; Hoshino T
    J Chem Inf Model; 2021 May; 61(5):2396-2406. PubMed ID: 33934602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
    Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
    J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
    Rezvani S; Ebadi A; Razzaghi-Asl N
    J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Structure and Conformational Stability of the Antigen Residues Making Contact with Antibodies.
    Qiao X; Qu L; Guo Y; Hoshino T
    J Phys Chem B; 2021 Oct; 125(41):11374-11385. PubMed ID: 34615354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response.
    Sharma V; Chouhan P; Pandey RK; Ojha R; Aathmanathan VS; Krishnan M; Prajapati VK
    J Biomol Struct Dyn; 2021 Jul; 39(11):4051-4065. PubMed ID: 32448082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
    Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
    MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
    Manjula S; Sivanandam M; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a HIV-1 subtype C 3D model using homology modeling and in-silico docking, molecular dynamics simulation, and MM-GBSA calculation of second-generation HIV-1 maturation inhibitor(s).
    K C Y; Pal S; Nitz TJ; Wild C; Gaur R
    J Biomol Struct Dyn; 2023 Jul; ():1-10. PubMed ID: 37489057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.